MTH Antibodies

Santa Cruz Biotechnology delivers a wide array of MTH Antibodies for the detection and analysis of methylenetetrahydrofolate reductase (MTHFR). MTH Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Methylenetetrahydrofolate reductase plays a central role in the folate metabolism pathway, converting 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, which is essential for DNA synthesis and repair. Variants in the MTHFR gene have been associated with various health conditions, including cardiovascular diseases and neural tube defects. Research focused on MTHFR continues to reveal new insights into metabolic disorders and potential therapeutic approaches. MTH monoclonal antibodies enable precise detection and quantification of MTHFR expression levels across diverse experimental conditions. Investigating MTHFR function and regulation advances our understanding of folate metabolism and its impact on human health. Understanding methylenetetrahydrofolate reductase activity patterns helps identify new therapeutic strategies for related disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of MTHFR and its role in human health and disease.